Special Care Bases (No Added Actives)

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

Squalane is listed as an emollient in this development reference. The recorded formula also lists Caprylic/Capric Triglyceride and Butyrospermum Parkii Butter. Review spreading, slip and the finish of the complete formula.

3. Typical use levels (formulation guide)

• Reference component allocation: 24% w/w.

Add Squalane through the oil phase; no additional wax-processing shear step is called for.

4. Regulatory sources & global compliance

• This record describes a development reference; it does not approve the supplied grade or finished product; It does not establish approval for the finished cosmetic.

5. Safety & risk assessment

The concentration shown is guidance for cosmetic formulation; the listed level does not itself confer drug or OTC status so patch response and stability should be checked on the finished product.

6. Stability & packaging

Store the bulk in a closed container in a cool, shaded place; where appropriate, assess an airless or pump pack for oxidation-sensitive systems; check the finished formula and its packaging together.

7. Claims language (Do / Don’t)

• The cosmetic role of Squalane is presented as a light-emollient role.

• The development record provides no basis for therapeutic outcomes, clinical cures, or a certification the finished SKU does not hold.
• The formulation record for Squalane does not support whitening, treatment of acne, perspiration control, sun protection, or hair growth.

1. INCI & CAS

INCI: Butyrospermum Parkii Butter · CAS: 91080-23-8

2. Role in the formula

Butyrospermum Parkii Butter is listed as a butter in this development reference. The recorded formula also lists Caprylic/Capric Triglyceride and Squalane. Review the contribution to body and application feel in the complete formula.

3. Typical use levels (formulation guide)

• In this reference, the component allocation is 20% w/w.

Incorporate melted Butyrospermum Parkii Butter in the oil phase and maintain shear during cooling to reduce grain formation.

4. Regulatory sources & global compliance

• The page provides development guidance; it establishes no approval for the raw material or the final product; The completed formula is not approved by this reference.

5. Safety & risk assessment

The use-level note is a reference for cosmetic formulation; it should not be read as a drug authorization or OTC listing with patch assessment and finished-formula stability testing still required.

6. Stability & packaging

Keep the ingredient in cool, closed bulk storage away from sunlight; select packaging with the formula's oxidation sensitivity in mind; verify the chosen pack against the tested formula.

7. Claims language (Do / Don’t)

• The listed cosmetic direction for Butyrospermum Parkii Butter emphasizes shea cushion.

• This formulation entry cannot substantiate drug effects, clinical cures, or unsupported product certifications.
• The formulation record for Butyrospermum Parkii Butter should not be cited in support of a whitening effect, acne treatment, perspiration control, sun protection, or hair growth.